Jenscare Scientific Co. Ltd. held its 2024 Annual General Meeting on May 22, 2025. The meeting saw the approval of several proposals, including the re-election of directors, approval of the audited financial statements, and the appointment of auditors. All proposals presented at the meeting were approved by the shareholders.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.